Rockwell Medical Inc (NASDAQ:RMTI) hit a new 52-week low during trading on Thursday . The stock traded as low as $3.54 and last traded at $3.59, with a volume of 457700 shares. The stock had previously closed at $3.86.

RMTI has been the topic of several research reports. ValuEngine upgraded shares of Rockwell Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, September 4th. Zacks Investment Research cut shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Tuesday, September 11th. Finally, Ifs Securities reiterated an “outperform” rating and issued a $11.00 price target on shares of Rockwell Medical in a research report on Friday, October 19th.

The stock has a market capitalization of $198.54 million, a P/E ratio of -8.59 and a beta of 1.42.

Rockwell Medical (NASDAQ:RMTI) last posted its quarterly earnings data on Friday, November 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.15) by $0.05. The firm had revenue of $16.67 million for the quarter, compared to the consensus estimate of $15.00 million. Rockwell Medical had a negative return on equity of 89.63% and a negative net margin of 55.38%. Analysts expect that Rockwell Medical Inc will post -0.64 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently bought and sold shares of RMTI. Sigma Investment Counselors Inc. raised its holdings in Rockwell Medical by 24.3% during the 3rd quarter. Sigma Investment Counselors Inc. now owns 86,834 shares of the company’s stock worth $366,000 after buying an additional 17,000 shares during the period. Schwab Charles Investment Management Inc. raised its holdings in Rockwell Medical by 13.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 108,942 shares of the company’s stock worth $538,000 after buying an additional 13,042 shares during the period. Raymond James & Associates raised its holdings in Rockwell Medical by 59.0% during the 2nd quarter. Raymond James & Associates now owns 128,276 shares of the company’s stock worth $632,000 after buying an additional 47,600 shares during the period. Finally, BlackRock Inc. raised its holdings in Rockwell Medical by 0.8% during the 3rd quarter. BlackRock Inc. now owns 3,221,245 shares of the company’s stock worth $13,593,000 after buying an additional 25,322 shares during the period. Hedge funds and other institutional investors own 22.15% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Rockwell Medical (RMTI) Reaches New 12-Month Low at $3.54” was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2018/11/10/rockwell-medical-rmti-reaches-new-12-month-low-at-3-54.html.

Rockwell Medical Company Profile (NASDAQ:RMTI)

Rockwell Medical, Inc operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment.

Read More: Insider Trading

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.